Job Posting: System Director of Structural Echo
Position Title: Director of Structural Echo
Location: Lankenau Medical Center/Main Line Health, Wynnewood, PA
Organization: Lankenau Heart Group of Main Line Healthcare
Employment Type: Full-Time
Reports To: Chief of Cardiovascular Division, Main Line Health
Position Overview
We are seeking a highly skilled and experienced Director of Structural Echo to lead our Structural Echocardiography program. This leadership role is integral to our continued excellence in cardiac imaging, providing high-quality patient care, and supporting our ongoing regional/national leadership in cardiovascular health. The successful candidate will oversee all aspects of the Structural Echo program, including clinical operations, research initiatives, and education.
This role will be uniquely central to the Structural Heart program activities. All referred Structural patients will initially have a clinical and imaging evaluation by the Director of Structural Echo along with a team of Advanced Practice Providers who would then direct their subsequent visits for imaging, physician and research considerations and ultimately participate in the Heart Team final recommendations for treatment.
Key Responsibilities
Qualifications
Why Join Us?
Lankenau Medical Center, offering tertiary and quaternary care, is a comprehensive medical complex located on 93 acres just outside the western city limits of Philadelphia.
Diversity is a core value at Main Line Health. We are committed to creating a diverse environment and are proud to be an equal opportunity employer.
More about Lankenau Heart Group: Building Hope with Ground-breaking Care
• The team of cardiologists and cardiovascular surgeons in one of the top-performing cardiovascular programs and among the region’s most trusted for cardiac care
• Nationally recognized clinical and basic research conducted through the Lankenau Institute for Medical Research (LIMR) providing access to the latest cardiovascular clinical trials, including novel medical devices, minimally invasive procedures, and medical therapies, many of which are not offered at other hospitals. Participation in multiple Early Feasibility Studies program, giving our patients opportunities for care only available at a handful of advanced institutions in the world
• Nationally recognized clinician experts who specialize in minimally invasive treatment options:
o More experience in minimally invasive robotic CABG/hybrid procedures than any hospital in the country—more than 2,200 procedures performed
o At the forefront of advancing TAVR for patients with severe aortic stenosis as well as aortic regurgitation
o Advanced investigational transcatheter-based novel technologies to treat aortic, mitral and tricuspid valve disease, in addition to multiple HF trials, both pharmaceutical and device-based.
o One of only a few programs in the country performing complex aortic surgery
o Peripheral intervention and endovascular options to treat vascular conditions, including PAD, DVT, carotid and venous disease with an active PERT program
• The latest in preventive cardiology including cardiovascular genetics
• Busy and growing advanced imaging programs including cardiac MR and Heartflow CCTA scans